This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Merck + Co., Inc.. Active years: 2001.
Company Filing History:
Years Active: 2001
Title: Innovations of Deborah D. Jones
Introduction
Deborah D. Jones is a notable inventor based in Bala Cynwyd, PA (US). She has made significant contributions to the field of biotechnology, particularly through her innovative work on modified PE40 toxin fusion proteins. Her research has implications for targeted therapies in medicine.
Latest Patents
Deborah D. Jones holds 1 patent for her invention of modified PE40 toxin fusion proteins. This invention involves the modification of the PE toxin by removing at least two of its four cysteine amino acid residues. She has developed hybrid molecules that link modified PE to cell recognition proteins, such as antibodies, growth factors, hormones, lymphokines, or other polypeptides. This innovative approach allows the modified PE toxin to be directed to specific cell types that have receptors for the linked cell recognition proteins.
Career Highlights
Throughout her career, Deborah has worked with prominent companies, including Merck & Co., Inc. and Allen I. Oliff. Her experience in these organizations has contributed to her expertise in the field of biotechnology and patent development.
Collaborations
Deborah has collaborated with notable individuals such as Allen I. Oliff and Gwynneth M. Edwards. These partnerships have enhanced her research and development efforts in the biotechnology sector.
Conclusion
Deborah D. Jones is a pioneering inventor whose work on modified PE40 toxin fusion proteins showcases her innovative spirit and dedication to advancing medical science. Her contributions continue to influence the field of biotechnology and highlight the importance of targeted therapies.